HomeTrading IdeasVolatility Playbook: 3 Lessons...

Volatility Playbook: 3 Lessons on How to Trade Headline-Driven Markets

Lately, volatility has been off the charts. We’re seeing triple-digit swings in stocks, and the market is getting a real taste of the wild ride that comes with a president who makes game-changing announcements almost daily. These moves don’t just shake up the U.S. economy—they send ripples across global markets.

If there’s one thing to take away from the past few weeks, it’s that volatility isn’t going anywhere. Learning how to navigate these unpredictable markets is no longer optional—it’s a necessity.

Having lived through more than a few chaotic market cycles, I’ve picked up some hard-earned lessons. And let me tell you, trading during extreme volatility is nothing like those YouTube videos promising you can turn $500 into a million overnight.

Markets don’t move smoothly from one level to another. Volatility is more like the famous Mike Tyson quote:

“Everyone has a plan until they get punched in the face.”

Lesson #1: Reduce Your Size

If you’re trading leveraged products like Forex or CFDs, you can lose half your account in minutes during fast markets. If you are trading prop accounts, your drawdown limits could be hit quickly. That’s why rule number one is simple: cut your position size.

Yes, I’m serious. It may feel ridiculous to trade micro contracts for example, but trust me—it’s the best decision you’ll make when markets go haywire.

Sure, there are traders out there who thrive in volatility, raking in massive gains by increasing size at the right moment. But let’s be real: You’re probably not one of them. Most traders think they’re the next George Soros, but in reality, we’re all just George Costanza—panicking, second-guessing, and getting whipsawed into oblivion.

Unless you’re trading at micro size, your account might not make it past lunchtime.

Lesson #2: Widen Your Stops and Targets

Fast-moving markets require bigger stops and wider targets. A good rule of thumb: for every 1% move beyond the average daily range, widen your stops and targets by 0.5x.

For example:
If the stock market’s normal daily range is 1% but swings to 5%, your stops and targets need to expand by a factor of 2.5.

This isn’t a perfect science, but like duct tape, it works well enough to keep you in the game.

Lesson #3: Turn OFF Your Robot EAs

Retail trading robots or EAs aren’t built for high-volatility markets. Even if they pick the right direction, they’ll often get stopped out before the trade has a chance to work.

There’s nothing worse than watching your robot stop you out five times in a row—on trades that should have made you money. It’s a special kind of torture that only extreme markets can deliver.

When things get crazy, trading becomes less of a strategic game and more of a high-frequency trading pinball machine. Ironically, when machines take over the market, the best move is to turn yours off.

Volatile markets aren’t the time to show off. The glory is short-lived, the wins fleeting, and the losses brutal. Survival should be your number one goal.

You’ll walk away feeling much better if you make it through the storm unscathed—rather than trying to be a hero and getting wiped out in the process.

Stay smart, stay disciplined, and most importantly—stay in the game.

Most Popular

More from Author

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? – ZyVersa Therapeutics (NASDAQ:ZVSA)

ZyVersa Therapeutics, Inc. ZVSA stock was trading higher on Tuesday, with a...

US Dollar Gains as Tariff Letters Erode Risk Appetite

Trump letters and August 1 deadline in focus Dollar strengthens as both...

Why CARGO Therapeutics Stock Is Gaining Today – Cargo Therapeutics (NASDAQ:CRGX)

CARGO Therapeutics Inc. CRGX saw its stock climb on Tuesday after...

Read Now

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? – ZyVersa Therapeutics (NASDAQ:ZVSA)

ZyVersa Therapeutics, Inc. ZVSA stock was trading higher on Tuesday, with a session volume of 160.9 million compared to the average volume of 4.03 million as per data from Benzinga Pro.What HappenedZyVersa Therapeutics provided regulatory and product support for FDA-authorized Emergency Compassionate Use of Cholesterol Efflux Mediator VAR 200...

US Dollar Gains as Tariff Letters Erode Risk Appetite

Trump letters and August 1 deadline in focus Dollar strengthens as both China and the EU avoid tariff letters Equities are wobbly, while gold confirms lingering demand Aussie gains as RBA surprises by keeping rates unchanged Liberation Date: Version 2The approval of the US Budget Bill has allowed US President Trump...

Wall Street Is On Fire—So Why Is This Wall Of Cash Moving Abroad? – iShares Core MSCI Emerging Markets ETF (ARCA:IEMG)

U.S. stocks may be breaking records, but a flood of investor cash is moving elsewhere—toward emerging markets, where valuations are cheaper, currencies are strengthening and years of underperformance may finally be reversing.The iShares Core MSCI Emerging Markets ETF IEMG has attracted $7.4 billion in inflows so far...

Why CARGO Therapeutics Stock Is Gaining Today – Cargo Therapeutics (NASDAQ:CRGX)

CARGO Therapeutics Inc. CRGX saw its stock climb on Tuesday after the biotech firm announced a merger agreement with Concentra Biosciences LLC.Under the terms of the agreement, Concentra will acquire CARGO for $4.379 in cash per share, along with a non-transferable contingent value right.The CVR entitles shareholders...

Gold Prices Slip Amid Trump’s Tariff Delay and Fed Rate Cut Speculations

Gold Pressured by Trade Tariffs On Monday, U.S. President Donald Trump posted letters on Truth Social addressed to the leaders of 14 countries. He threatened to impose tariffs ranging from 25% to 40% on imports unless countries address trade imbalances. The letters targeted China, Germany, Japan, Mexico, and...

Artelo Biosciences Analyst See It As An Emerging Biotech – Artelo Biosciences (NASDAQ:ARTL)

D. Boral Capital upgraded Artelo Biosciences, Inc. ARTL on Tuesday.The analyst upgraded from Hold to Buy and introduced a price forecast of $20.Analyst Jason Kolbert wrote, “We continue to view Artelo as an emerging biotechnology company focused on Cachexia and chemotherapy-induced peripheral neuropathy (CIN) with the lead...

Oil Prices Rebound Despite OPEC+ Output Hike as Markets Rethink Supply Risk

surged yesterday after gapping down over the weekend. The gap down came about as the + group, which includes OPEC and its allies, agreed to increase oil production by 548,000 barrels per day in August. This is a bigger rise compared to the 411,000 barrels per day...

Asian Stocks Climb as Trump Signals Openness to Trade Talks Before Tariff Deadline

Asian stock markets remained steady despite the latest update on US President Donald Trump’s tariff plans. On Tuesday, the stayed strong, and dropped. In the US, stock prices fell after Trump sent letters to 14 countries, including Japan and South Korea, announcing much higher tariffs on...

Why Is Cogent Biosciences Stock Soaring On Tuesday? – Cogent Biosciences (NASDAQ:COGT)

On Monday, Cogent Biosciences, Inc. COGT said bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis.The company said that its experimental drug reduced the symptoms of a chronic immune disorder called non-advanced systemic mastocytosis.The latest study demonstrated meaningful and highly statistically significant improvements across the...

Are Markets Underpricing the Next Tariff Shock?

Economic activity appears set to strengthen in the official Q2 , but the second half of the year looks relatively vulnerable. One factor is the possibility that the simmering trade war may heat up after President Trump on Monday announced new tariffs set to begin on August...

Does Higher Dose Of Wegovy Result In More Weight Loss – Novo Nordisk (NYSE:NVO)

Novo Nordisk A/S NVO on Tuesday announced that it has submitted an application to the European Medicines Agency (EMA) for approval of a new, higher dose of its obesity treatment, Wegovy (subcutaneous semaglutide 7.2 mg).The submission is based on clinical data from the STEP UP and STEP...

Why Is Penny Stock ProKidney Trading Higher On Tuesday? – ProKidney (NASDAQ:PROK)

ProKidney Corp. PROK stock is trading higher on Tuesday, with a session volume of 39.8 million compared to the average volume of 1.12 million as per data from Benzinga Pro.What happened: The chronic kidney disease (CKD)-focused company reported statistically significant and clinically meaningful positive topline results from...